Increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma
Olga Maria Will,1,* Nicolai Purcz,2,* Athena Chalaris,3 Carola Heneweer,4,5 Susann Boretius,1 Larissa Purcz,2 Lila Nikkola,6 Nureddin Ashammakhi,6 Holger Kalthoff,7 Claus-Christian Glüer,1 Jörg Wiltfang,2 Yahya Açil,2 Sanjay Tiwari1 1Section Biomedical Imaging, Clinic f...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5335260a745c44bcb326c964dc9b1030 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5335260a745c44bcb326c964dc9b1030 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5335260a745c44bcb326c964dc9b10302021-12-02T00:45:07ZIncreased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma1178-2013https://doaj.org/article/5335260a745c44bcb326c964dc9b10302016-10-01T00:00:00Zhttps://www.dovepress.com/increased-survival-rate-by-local-release-of-diclofenac-in-a-murine-mod-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Olga Maria Will,1,* Nicolai Purcz,2,* Athena Chalaris,3 Carola Heneweer,4,5 Susann Boretius,1 Larissa Purcz,2 Lila Nikkola,6 Nureddin Ashammakhi,6 Holger Kalthoff,7 Claus-Christian Glüer,1 Jörg Wiltfang,2 Yahya Açil,2 Sanjay Tiwari1 1Section Biomedical Imaging, Clinic for Radiology and Neuroradiology, MOIN CC, 2Department of Oral and Maxillofacial Surgery, University Hospital Schleswig-Holstein, 3Institute of Biochemistry, Christian-Albrechts-Universität zu Kiel, 4Clinic for Radiology and Neuroradiology, University Hospital Schleswig-Holstein, Kiel, 5Institute for Diagnostic and Interventional Radiology, University Hospital Cologne, Cologne, Germany; 6Department of Biomedical Engineering, Tampere University of Technology, Tampere, Finland; 7Institute for Experimental Cancer Research, University Hospital Schleswig-Holstein, Kiel, Germany *These authors contributed equally to this work Abstract: Despite aggressive treatment with radiation and combination chemotherapy following tumor resection, the 5-year survival rate for patients with head and neck cancer is at best only 50%. In this study, we examined the therapeutic potential of localized release of diclofenac from electrospun nanofibers generated from poly(d,l-lactide-co-glycolide) polymer. Diclofenac was chosen since anti-inflammatory agents that inhibit cyclooxygenase have shown great potential in their ability to directly inhibit tumor growth as well as suppress inflammation-mediated tumor growth. A mouse resection model of oral carcinoma was developed by establishing tumor growth in the oral cavity by ultrasound-guided injection of 1 million SCC-9 cells in the floor of the mouth. Following resection, mice were allocated into four groups with the following treatment: 1) no treatment, 2) implanted scaffolds without diclofenac, 3) implanted scaffolds loaded with diclofenac, and 4) diclofenac given orally. Small animal ultrasound and magnetic resonance imaging were utilized for longitudinal determination of tumor recurrence. At the end of 7 weeks following tumor resection, 33% of mice with diclofenac-loaded scaffolds had a recurrent tumor, in comparison to 90%–100% of the mice in the other three groups. At this time point, mice with diclofenac-releasing scaffolds showed 89% survival rate, while the other groups showed survival rates of 10%–25%. Immunohistochemical staining of recurrent tumors revealed a near 10-fold decrease in the proliferation marker Ki-67 in the tumors derived from mice with diclofenac-releasing scaffolds. In summary, the local application of diclofenac in an orthotopic mouse tumor resection model of oral cancer reduced tumor recurrence with significant improvement in survival over a 7-week study period following tumor resection. Local drug release of anti-inflammatory agents should be investigated as a therapeutic option in the prevention of tumor recurrence in oral squamous carcinoma. Keywords: tumor recurrence, oral squamous cell carcinoma, head and neck cancer, NSAIDs, drug releasing polymers, mouse model Will OMPurcz NChalaris AHeneweer CBoretius SPurcz LNikkola LAshammakhi NKalthoff HGlüer CCWiltfang JAçil YTiwari SDove Medical PressarticleTumor recurrenceoral squamous cell carcinomahead and neck cancerNSAIDSdrug releasing polymersmouse modelMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 11, Pp 5311-5321 (2016) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Tumor recurrence oral squamous cell carcinoma head and neck cancer NSAIDS drug releasing polymers mouse model Medicine (General) R5-920 |
spellingShingle |
Tumor recurrence oral squamous cell carcinoma head and neck cancer NSAIDS drug releasing polymers mouse model Medicine (General) R5-920 Will OM Purcz N Chalaris A Heneweer C Boretius S Purcz L Nikkola L Ashammakhi N Kalthoff H Glüer CC Wiltfang J Açil Y Tiwari S Increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma |
description |
Olga Maria Will,1,* Nicolai Purcz,2,* Athena Chalaris,3 Carola Heneweer,4,5 Susann Boretius,1 Larissa Purcz,2 Lila Nikkola,6 Nureddin Ashammakhi,6 Holger Kalthoff,7 Claus-Christian Glüer,1 Jörg Wiltfang,2 Yahya Açil,2 Sanjay Tiwari1 1Section Biomedical Imaging, Clinic for Radiology and Neuroradiology, MOIN CC, 2Department of Oral and Maxillofacial Surgery, University Hospital Schleswig-Holstein, 3Institute of Biochemistry, Christian-Albrechts-Universität zu Kiel, 4Clinic for Radiology and Neuroradiology, University Hospital Schleswig-Holstein, Kiel, 5Institute for Diagnostic and Interventional Radiology, University Hospital Cologne, Cologne, Germany; 6Department of Biomedical Engineering, Tampere University of Technology, Tampere, Finland; 7Institute for Experimental Cancer Research, University Hospital Schleswig-Holstein, Kiel, Germany *These authors contributed equally to this work Abstract: Despite aggressive treatment with radiation and combination chemotherapy following tumor resection, the 5-year survival rate for patients with head and neck cancer is at best only 50%. In this study, we examined the therapeutic potential of localized release of diclofenac from electrospun nanofibers generated from poly(d,l-lactide-co-glycolide) polymer. Diclofenac was chosen since anti-inflammatory agents that inhibit cyclooxygenase have shown great potential in their ability to directly inhibit tumor growth as well as suppress inflammation-mediated tumor growth. A mouse resection model of oral carcinoma was developed by establishing tumor growth in the oral cavity by ultrasound-guided injection of 1 million SCC-9 cells in the floor of the mouth. Following resection, mice were allocated into four groups with the following treatment: 1) no treatment, 2) implanted scaffolds without diclofenac, 3) implanted scaffolds loaded with diclofenac, and 4) diclofenac given orally. Small animal ultrasound and magnetic resonance imaging were utilized for longitudinal determination of tumor recurrence. At the end of 7 weeks following tumor resection, 33% of mice with diclofenac-loaded scaffolds had a recurrent tumor, in comparison to 90%–100% of the mice in the other three groups. At this time point, mice with diclofenac-releasing scaffolds showed 89% survival rate, while the other groups showed survival rates of 10%–25%. Immunohistochemical staining of recurrent tumors revealed a near 10-fold decrease in the proliferation marker Ki-67 in the tumors derived from mice with diclofenac-releasing scaffolds. In summary, the local application of diclofenac in an orthotopic mouse tumor resection model of oral cancer reduced tumor recurrence with significant improvement in survival over a 7-week study period following tumor resection. Local drug release of anti-inflammatory agents should be investigated as a therapeutic option in the prevention of tumor recurrence in oral squamous carcinoma. Keywords: tumor recurrence, oral squamous cell carcinoma, head and neck cancer, NSAIDs, drug releasing polymers, mouse model |
format |
article |
author |
Will OM Purcz N Chalaris A Heneweer C Boretius S Purcz L Nikkola L Ashammakhi N Kalthoff H Glüer CC Wiltfang J Açil Y Tiwari S |
author_facet |
Will OM Purcz N Chalaris A Heneweer C Boretius S Purcz L Nikkola L Ashammakhi N Kalthoff H Glüer CC Wiltfang J Açil Y Tiwari S |
author_sort |
Will OM |
title |
Increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma |
title_short |
Increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma |
title_full |
Increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma |
title_fullStr |
Increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma |
title_full_unstemmed |
Increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma |
title_sort |
increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma |
publisher |
Dove Medical Press |
publishDate |
2016 |
url |
https://doaj.org/article/5335260a745c44bcb326c964dc9b1030 |
work_keys_str_mv |
AT willom increasedsurvivalratebylocalreleaseofdiclofenacinamurinemodelofrecurrentoralcarcinoma AT purczn increasedsurvivalratebylocalreleaseofdiclofenacinamurinemodelofrecurrentoralcarcinoma AT chalarisa increasedsurvivalratebylocalreleaseofdiclofenacinamurinemodelofrecurrentoralcarcinoma AT heneweerc increasedsurvivalratebylocalreleaseofdiclofenacinamurinemodelofrecurrentoralcarcinoma AT boretiuss increasedsurvivalratebylocalreleaseofdiclofenacinamurinemodelofrecurrentoralcarcinoma AT purczl increasedsurvivalratebylocalreleaseofdiclofenacinamurinemodelofrecurrentoralcarcinoma AT nikkolal increasedsurvivalratebylocalreleaseofdiclofenacinamurinemodelofrecurrentoralcarcinoma AT ashammakhin increasedsurvivalratebylocalreleaseofdiclofenacinamurinemodelofrecurrentoralcarcinoma AT kalthoffh increasedsurvivalratebylocalreleaseofdiclofenacinamurinemodelofrecurrentoralcarcinoma AT gluercc increasedsurvivalratebylocalreleaseofdiclofenacinamurinemodelofrecurrentoralcarcinoma AT wiltfangj increasedsurvivalratebylocalreleaseofdiclofenacinamurinemodelofrecurrentoralcarcinoma AT acily increasedsurvivalratebylocalreleaseofdiclofenacinamurinemodelofrecurrentoralcarcinoma AT tiwaris increasedsurvivalratebylocalreleaseofdiclofenacinamurinemodelofrecurrentoralcarcinoma |
_version_ |
1718403495584858112 |